Under construction – not a live service
Sign in
Taking people in IsraelNo phase

Studies factors linked to amyotrophic lateral sclerosis in Israel

Observes people with ALS and records their health details over time.

Plain-language title generated from the registry record
Registry title: Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)

Key facts

Where
Jerusalem, IsraelSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 120 years old?

Source: NCT03366506, who can take part

Where in Israel

  • Hadassah Medical OrganisationJerusalem, IsraelTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Hadassah Medical Organization
Trial code
NCT03366506
Record updated
10 February 2021
Original description
Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-Read full original descriptionShow less

Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-

1. Differences between ethnic subgroups 2. Differences between immigrant and native-born populations 3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.

Inclusion: Suspected, possible, probable ,definite ALS.

Exclusion: -.

ClinicalTrials.gov NCT03366506